Focus Sectors | Verticals
MedTech
MedTech is where Switzerland’s deep heritage in precision engineering, microtechnology, and life sciences converges to solve critical healthcare challenges. This vertical is focused on tangible medical devices for surgery, patient monitoring, advanced diagnostics, and clinical support, integrating disciplines like robotics and AI to improve patient outcomes.
For this reason, “MedTech is Switzerland’s natural playground”. The ecosystem’s single greatest advantage is its “tight loop between engineers, clinicians, and regulators”, which allows startups to de-risk innovation and iterate solutions at a speed rarely seen elsewhere. With over 150 VC-backed startups and $1.4B in funding since 2019, the sector successfully integrates multiple disciplines to build value-based business models that are ready for global markets.
This page provides a detailed look at this powerhouse sector. Explore the key statistics, discover the “companies to watch” in fields from telerobotics to AI-powered diagnostics, and learn how Swiss MedTech teams are building the future of healthcare.
Key Stats*
150+
VC-Backed startups
$1.4B
VC funding since 2019
$6.1B
Combined Enterprise Value
Tob Hubs in Zurich, Lausanne (EPFL) and Geneva.
* All data is taken from the Swiss Deep Tech Report 2025.
Companies to watch
Cell line technology for gene therapy.
Immune system rejuvenation.
Modular AI solutions accelerating drug discovery.
AI fingerprinting technology for molecular identification.
Genomic data.
Protein engineering.
Platform for cell and gene therapy manufacturing at scale.
RNA sequencing at scale.
The AI-first lab for protein design.
«The Swiss ecosystem gives Medtech teams the freedom to build, test, and scale ideas quickly. We see a tight loop between engineers, clinicians and regulators that lets us de-risk innovation fast. Once we prove a product here, we turn to the US for the deep capital, market scale and strategic partnerships that drive full commercial rollout and the path to public listing. By keeping robotics simple, surgeon-controlled, and cost-aligned, we can make advanced care a routine option for every hospital.»

Michael Friedrich
COO
Distalmotion
«Medtech is Switzerland’s natural playground. The depth of life science, shaped by Roche, Novartis, and a network of top universities, meets precision engineering, robotics, and increasingly Al. Integrating these dissimilar disciplines successfully is the key to innovation. Novel solutions allow to diagnose more accurately, treat more effectively, and build value based business models. It is at these crossroads of science and engineering where Zühlke Ventures keeps placing its bets.»

Patrick Griss
CEO Ventures & Partner
Zühlke
Who’s Who in MedTech
-
-

Bio-Technopark Schlieren-Zürich
Zurich
The Bio-Technopark is a life science park housing 60 companies and organizations, as well as 80 academic research groups. The park has offices and laboratories.
-

-
Boldbrain Startup Challenge
Lugano
Boldbrain Startup Challenge is an accelerator designed for early-stage startups and entrepreneurs with innovative ideas, ready to launch and develop their business from Canton Ticino.
-
-
Eawag: Swiss Federal Institute of Aquatic Science and Technology
Duebendorf
Eawag is one of the world’s leading aquatic research institutes.
-
EPFL Innovation Park
Lausanne
EPFL Innovation Park: A hive of interaction between academia and business, attracting outstanding, innovative projects and empowering them to flourish, scale up and transform society.
-
Most Active Swiss VCs in MedTech
-
Spicehaus Partners
Focus on early stage
ICT
-

StartAngels
Focus on early stag
ICT
-
Swisscanto
Focus on later stage
ICT
Participated in funding round of >100 mio.
Invested in Unicorn
-
VI partners
Focus on early stage
ICT
Participated in funding round of >100 mio.
Invested in Unicorn
-
Zürcher Kantonalbank
Focus on early stage
ICT
Invested in Unicorn
-
4FOx Ventures
Focus on early stage
Medtech
-

Alpana
Focus on early stage
ICT
-

BioMedPartners
Focus on early stage
Biotech
Participated in funding round of >100 mio.
-

Business Angels Switzerland
Focus on early stage
ICT
-

Kickfund
Focus on early stage
Climate Tech & Energy
Success Stories
-
Read more: Switzerland: A Leading Global Scale-up HubMore money has flowed into all Swiss scale-ups per capita than into scale-ups in the US or Israel. This is backed by a ten-year growth…
-
Read more: European Spinouts Report 2025: Switzerland Confirmed as Europe’s Deep Tech PowerhouseThe most critical metric in innovation is not volume but efficiency. While larger economies naturally produce higher absolute numbers of companies, the true measure of…
-
Read more: Why Deep Tech Pioneers and Private Equity are a MatchThis autumn saw notable activity from private equity investors in Switzerland, including a USD 500 million exit in addition to investments. Their preference for innovative…
MedTech
News
-
€13.9 million for glucose-monitoring wearable
Liom, the developer of the world’s first non-invasive glucose-monitoring wearable, has secured additional €13.9 million (CHF 13 million) in its Series A extension round, bringing…
startupticker.ch
-
Swiss delegation warms up for CES 2026 in Las Vegas
The upcoming year will again kick off with the annual Consumer Electronic Show (CES) in Las Vegas, held on 6-9 January 2026. Close to 150’000…
startupticker.ch
-
Startups score prizes across Asia and Germany
In recognition of their innovative solutions — from digitally printed solar cells and scenario-based modelling to sono-instruments and solar fuels — juries in Taiwan, the…
startupticker.ch
-
SwissHealth Ventures doubles fund volume to CHF 100 million
SwissHealth Ventures, the digital health investment arm of health insurer CSS, is set to continue backing high-growth start-ups in the healthcare sector over the coming…
startupticker.ch
-
Swiss startups across industries in the global spotlight
A host of awards were bestowed upon Swiss startups developing innovative solutions across sectors such as medtech, robotics, energy, and fashion. Along with cash prizes,…
startupticker.ch
-
$150 million to scale DEXTER the surgical robot across the US
Distalmotion, the developer of surgical robot DEXTER which is designed to empower access to the benefits of robotic surgery in outpatient sites of care, has…
startupticker.ch
FAQ on MedTech
1. Why is MedTech considered Switzerland’s “natural playground”?
The sector perfectly combines the country’s historic strengths: deep life science expertise, precision engineering, robotics, and, increasingly, AI.
2. What is the total VC funding for MedTech in Switzerland?
The Swiss MedTech sector has raised $1.4 billion between 2019 and 2024, with funding growing 410% in that period. 2024 was its most active funding year on record.
3. How does the Swiss ecosystem benefit MedTech startups?
The “tight loop between engineers, clinicians, and regulators” allows startups to “de-risk innovation fast”. This rapid, collaborative iteration is a key advantage for building complex medical devices.
4. Which are the leading Swiss MedTech companies in surgical robotics?
The sector is anchored by major scale-ups like Distalmotion, which is commercializing its surgical robot, and rising stars like nanoflex (telerobotics) and LEM surgical.
5. What are the key investment trends in Swiss medical device startups?
Key trends include AI-powered diagnostics (scanvio), advanced surgical robotics (Distalmotion), telerobotics (nanoflex), and novel therapeutic devices (hilo, ArgaMedtech).

